YR
Yadagiri R Pendri
About Yadagiri R Pendri
Data last updated:
Yadagiri R Pendri is a Director at Escientia Advanced Sciences Private Limited (since 2013), Director at Vimta Labs Limited (since 2020) and Director at Escientia Biopharma Private Limited (since 2008), and holds 1 more current directorship. The companies operate in Pharma and Travel and Hospitality. The 3 current companies with reported revenue have a combined latest revenue of ₹859 Cr; the largest is Escientia Advanced Sciences Private Limited at ₹423 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Feb 2013 | 2013 | ₹423 Cr (FY 2024) | Active | |
| Director | 10 Aug 2020 | 1990 | ₹416 Cr (FY 2026) | Active | |
| Director | 22 Jan 2008 | 2008 | ₹20.04 Cr (FY 2025) | Active | |
| Director | 01 Aug 2008 | 2008 | Active |
Board colleagues of Yadagiri R Pendri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yadagiri R Pendri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yadagiri R Pendri
Yadagiri R Pendri currently holds 4 directorships: Escientia Advanced Sciences Private Limited (Director, since 27 Feb 2013, revenue ₹423 Cr (FY 2024)); Vimta Labs Limited (Director, since 10 Aug 2020, revenue ₹416 Cr (FY 2026)); Escientia Biopharma Private Limited (Director, since 22 Jan 2008, revenue ₹20.04 Cr (FY 2025)); Escientia Lifesciences Private Limited (Director, since 01 Aug 2008).
Yadagiri R Pendri was first appointed on 22 Jan 2008 as Director at Escientia Biopharma Private Limited. The most recent appointment on record is 10 Aug 2020 at Vimta Labs Limited.
The 3 current companies of Yadagiri R Pendri that report revenue have a combined latest revenue of ₹859 Cr: Escientia Advanced Sciences Private Limited ₹423 Cr (FY 2024); Vimta Labs Limited ₹416 Cr (FY 2026); Escientia Biopharma Private Limited ₹20.04 Cr (FY 2025).
The current boards of Yadagiri R Pendri's companies include Ajit Alexander George (Escientia Advanced Sciences Private Limited), Dandu Chakradhar (Escientia Advanced Sciences Private Limited), Pendri Kiran Reddy (Escientia Advanced Sciences Private Limited), Srinivasa Rao Korada (Escientia Advanced Sciences Private Limited), Srinivasa Rao Korada (Escientia Advanced Sciences Private Limited), Vivek Vasant Save (Escientia Advanced Sciences Private Limited), among others.